Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,801-1,812 of 6,115
Drug study icon
Not recruitingEUCTR 2006-004716-48

Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder. A 6-week randomised, double-blind parallel groups study versus ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
France, United Kingdom, Austria, ...
Sponsor
Institut de Recherches Internationales Servier
Condition
Depression
Drug study icon
Not recruitingEUCTR 2021-006510-36

Exploring the Pharmacomicrobiomics of Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Nijmegen
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Netherlands
Sponsor
Radboudumc
Condition
Depression
Device study icon
Not recruitingISRCTN46722730

Helsinki improved transcranial magnetic stimulation for depression

This study is looking at care and outcomes for people with depression or Mental and Behavioural Disorders. Direct benefit is not guaranteed, but the study may help researchers improve future care.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
Finland
Sponsor
Hospital District of Helsinki and Uusimaa
Condition
Depression
Drug study icon
CompletedNCT02133001

Intranasal Esketamine for depression

This study is completed in the United States. It is testing intranasal Esketamine for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Other study type icon
CompletedNCT04159207

A Longitudinal Study of Inflammatory Pathways in Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Grand Rapids
Why is this study shown?

This study is directly about Depression.

DepressionObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
Van Andel Research Institute
Condition
Depression
Behavioral study icon
CompletedNCT06856668

A Megastudy of Single-Session Interventions for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Northwestern University
Condition
Depression
Drug study icon
CompletedNCT03505905

A Neurosteroid Intervention for Menopausal and Perimenopausal Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 40 Years to 67 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.